Honeywell

https://www.pharmtech.com/pt_w/blister_packaging

Stability and moisture challenges are likely to increase with the development of more potent APIs, larger molecules, and modified-release tablets. Innovative and evolving dosage forms, such as chewable and orally disintegrating tablets, also face heightened stability challenges and shelf-life challenges. In this webinar, learn about the trend of increasing moisture sensitivity of oral solid doses and discover solutions to increase efficiency and effectiveness of blister packaging technology.

Understand the impact of packaging choices on stability and shelf life of oral solid dose drugs

Review best practices and new techniques for barrier and shelf-life prediction

Learn about the benefits of combining new and novel blister packaging technologies

Francois Bidet, VP Business Development, EMEA, Aptar CSP Technologies

Jim Hollinger, Business Unit Manager – Extruded Film, Aptar CSP Technologies

Dr. Thomas Dries, Global Market Development Leader, Honeywell International

Kori Anderson, Global General Manager, Honeywell International

Thursday, Sept. 17, 2020 at 11am EDT| 8am PDT | 4pm BST | 5pm CEST

On demand available after airing until Sept. 17, 2021

Webcasts

Stability and moisture challenges are likely to increase with the development of more potent APIs, larger molecules, and modified-release tablets. Learn about innovative packaging solutions to address the increasing need to protect hydrophilic oral solid doses from moisture and preserve drug stability.
Live: 
Thursday, Sept. 17, 2020 at 11am EDT| 8am PDT | 4pm BST | 5pm CEST

On demand available after airing until Sept. 17, 2021

Active Packaging Reimagined: Novel Technologies to Derisk Drug Product Stability

Articles

Plan production automation around audit readiness and regulatory compliance. Understand data integrity considerations, infrastructure components, and new technologies supporting GxP.  


eBook:  Planning Audit-Ready Manufacturing Automation

In partnership with Honeywell, Axendia research sheds light on opportunities and challenges
experienced by leaders trying to modernize their life sciences production. 


Digital Transformation and Manufacturing Modernization

http://www.pharmtech.com/pt_w/business_continuity_practices

	The global coronavirus pandemic has tested the abilities of bio/pharmaceutical companies to develop new therapies and maintain-or even accelerate-production of existing drugs. Travel bans, restricted access to facilities, and supply chain disruptions are just a few of the challenges facing drug companies, that must provide essential medicines under adverse conditions while protecting their employees and adhering to good manufacturing practices.

	In the initial weeks of the coronavirus pandemic, bio/pharma companies, contract service providers, and regulatory authorities have taken measures to ensure continued operations during the present emergency. While addressing the challenges of today, the bio/pharma industry also needs to look ahead to what may be new operating conditions for the coming months or years.

 for interviews and discussions with experts about business continuity practices, regulatory compliance, and supply chain management under current-or future-emergency conditions.

		Testing guidance for new and existing drugs

		Data security, data integrity, and remote data access and collaboration

: Mary Blenn, vice-president, global supply chain, Cytiva

	Lisia Marina Scholz Dias, lead application engineer, Applied Materials

	Steve Goldman, head of Steve Goldman Associates, a risk management and business continuity consultancy

	Susan Schniepp, a distinguished fellow for Regulatory Compliance Associates

	Angelo Stracquatanio, CEO, apprentice.io

Tuesday, Apr. 28, 2020 at 11 am EDT | 10 am CDT | 8 am PDT

	On demand available after airing until Apr. 28, 2021.

The global coronavirus pandemic has tested the abilities of bio/pharmaceutical companies to develop new therapies and maintain-or even accelerate-production of existing drugs. In this webcast, experts will discuss business continuity practices, regulatory compliance, and supply chain management under current-or future-emergency conditions.

Live: Tuesday, Apr. 28, 2020 at 11 am EDT | 10 am CDT | 8 am PDT

On Demand: available after airing until Apr. 28, 2021 

Register free

Ensuring the Continuous Supply of Quality Drug Products During Uncertain Times

Learn how to use KPIs like Overall Equipment Effectiveness (OEE) to identify and close productivity gaps in batch manufacturing and improve product quality.